Researchers reported longitudinal outcomes among British women suffering from early invasive-type breast tumors as their initial tumor and those initially treated by surgical methods such as conservative surgery or mastectomy.
Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial | Psychedelic Invest
Vancouver, British Columbia–(Newsfile Corp. – August 28, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a GMP-compliant, Health